Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2026 17:30 ET | Source: Thérapeutique Knight inc.

Thérapeutique Knight inc. annonce le remboursement de sa facilité de crédit renouvelable

MONTRÉAL, 17 juin 2026 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique panaméricaine (ex-ÉU), a annoncé aujourd’hui qu’elle a remboursé tous les...
June 17, 2026 17:00 ET | Source: Satellos Bioscience Inc.

Satellos Bioscience Announces Results of Annual Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving...
June 17, 2026 16:46 ET | Source: Texas Ventures Acquisition IV Corp

Texas Ventures Acquisition IV Corp Announces the Pricing of $150,000,000 Initial Public Offering

New York, NY, June 17, 2026 (GLOBE NEWSWIRE) -- Texas Ventures Acquisition IV Corp (the “Company”) announced today the pricing of its initial public offering of 150,000,000 units. The units are...
June 17, 2026 16:30 ET | Source: Certara

Certara Announces CFO Transition

RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified...
June 17, 2026 16:30 ET | Source: Hudbay Minerals Inc.

Hudbay Announces Pricing for US$52 Million of Municipal Bonds for Copper World at 4.50%

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the pricing of an offering of US$52 million in aggregate principal amount...
June 17, 2026 16:30 ET | Source: Biodexa Pharmaceuticals PLC

Postponement and Re-scheduling of Annual General Meeting

June 17, 2026 Biodexa Pharmaceuticals PLC Postponement and Re-scheduling of Annual General Meeting Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “Company”), a clinical stage...
June 17, 2026 16:20 ET | Source: Collective Acquisition Corp. II

Collective Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026

Miami, FL, June 17, 2026 (GLOBE NEWSWIRE) -- Collective Acquisition Corp. II (Nasdaq: CAIIU) (the “Company”) announced today that, commencing June 22, 2026, holders of the units issued in the...
June 17, 2026 16:16 ET | Source: Rumble, Inc.

Rumble Announces Realignment into Two Core Business Units and Renames Newly Acquired Cloud And AI-Infrastructure Business “Quake AI”

Rumble Announces Realignment into Two Core Business Units and Renames Newly Acquired Cloud And AI-Infrastructure Business “Quake AI”
June 17, 2026 16:15 ET | Source: Odyssey Therapeutics Inc

Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reported positive clinical proof-of-concept data for OD-001 in a Phase 2a monotherapy trial for moderate to severe ulcerative colitis.
June 17, 2026 16:13 ET | Source: National Healthcare Properties

National Healthcare Properties Announces Preliminary Results of its Series A and Series B Preferred Stock Self Tender Offers

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP / NHPAP / NHPBP) (the “Company”), a self-managed real estate investment trust focused on acquiring,...